Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Mol Ecol ; 32(12): 3200-3219, 2023 06.
Article in English | MEDLINE | ID: mdl-36943181

ABSTRACT

Little is known about when and how planktonic species arise and persist in the open ocean without apparent dispersal barriers. Pteropods are planktonic snails with thin shells susceptible to dissolution that are used as bio-indicators of ocean acidification. However, distinct evolutionary units respond to acidification differently, and defining species boundaries is therefore crucial for predicting the impact of changing ocean conditions. In this global population genomic study of the shelled pteropod Limacina bulimoides, we combined genetic (759,000 single nucleotide polymorphisms) and morphometric data from 161 individuals, revealing three major genetic lineages (FST = 0.29-0.41): an "Atlantic lineage" sampled across the Atlantic, an "Indo-Pacific lineage" sampled in the North Pacific and Indian Ocean, and a "Pacific lineage" sampled in the North and South Pacific. A time-calibrated phylogeny suggests that the lineages diverged about 1 million years ago, with estimated effective population size remaining high (~10 million) throughout Pleistocene glacial cycles. We do not observe any signatures of recent hybridization, even in areas of sympatry in the North Pacific. While the lineages are reproductively isolated, they are morphologically cryptic, with overlapping shell shape and shell colour distributions. Despite showing that the circumglobal L. bulimoides consists of multiple species with smaller ranges than initially thought, we found that these pteropods still possess high levels of genetic variability. Our study adds to the growing evidence that speciation is often overlooked in the open ocean, and suggests the presence of distinct biological species within many other currently defined circumglobal planktonic species.


Subject(s)
DNA, Mitochondrial , Plankton , Humans , Animals , Phylogeography , Plankton/genetics , Hydrogen-Ion Concentration , DNA, Mitochondrial/genetics , Seawater , Phylogeny , Snails/genetics
2.
Int J Tuberc Lung Dis ; 25(10): 814-822, 2021 10 01.
Article in English | MEDLINE | ID: mdl-34615578

ABSTRACT

BACKGROUND: Recruitment to randomised clinical trials can be challenging and slow recruitment has serious consequences. This study aimed to summarise and reflect on the challenges in enrolling young children to a multidrug-resistant TB (MDR-TB) prevention trial in South Africa.METHODS: Recruitment to the Tuberculosis Child Multidrug-resistant Preventive Therapy Trial (TB-CHAMP) was tracked using an electronic recruiting platform, which was used to generate a recruiting flow diagram. Structured personnel questionnaires, meeting minutes and workshop notes were thematically analysed to elucidate barriers and solutions.RESULT: Of 3,682 (85.3%) adult rifampicin (RIF) resistant index cases with pre-screening outcomes, 1597 (43.4%) reported having no children under 5 years in the household and 562 (15.3%) were RIF-monoresistant. More than nine index cases were pre-screened for each child enrolled. Numerous barriers to recruitment were identified. Thorough recruitment planning, customised tracking data systems, a dedicated recruiting team with strong leadership, adequate resources to recruit across large geographic areas, and excellent relationships with routine TB services emerged as key factors to ensure successful recruitment.CONCLUSION: Recruitment of children into MDR-TB prevention trials can be difficult. Several MDR-TB prevention trials are underway, and lessons learnt from TB-CHAMP will be relevant to these and other TB prevention studies.


Subject(s)
Mycobacterium tuberculosis , Tuberculosis, Multidrug-Resistant , Adult , Child , Child, Preschool , Clinical Trials as Topic , Family Characteristics , Humans , Mass Screening , Research Design , Rifampin , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Multidrug-Resistant/prevention & control
3.
Trop Biomed ; 38(4): 552-560, 2021 Dec 01.
Article in English | MEDLINE | ID: mdl-35001921

ABSTRACT

Understanding of antibody kinetics against SARS-CoV-2 and its vaccines is rapidly evolving. This study aims to (1) determine post-vaccination seroprevalence; (2) compare antibody levels between vaccine types and various clinical/demographic determinants; and (3) determine post-vaccination antibody concentrations against time. This is a retrospective cross-sectional study involving 148 healthcare employees all over Malaysia. IgG Spike (RBD), IgM Spike and IgG Nucleocapsid concentration medians were compared using Mann-Whitney U or Kruskal-Wallis tests. Chi Square and Spearman correlation coefficient tests were performed to identify variables associated with antibody titers. A scatter plot of IgG Spike (RBD) against time from last vaccine dose was also plotted. At 1-month post-vaccination, all employees successfully seroconverted regardless of vaccine type, health status and COVID- 19 history. Comirnaty, convalescent, female or Malay vaccinees had significantly higher IgG Spike (RBD) titers compared to their respective counterparts. No correlation was found between age and IgG Spike (RBD) levels. Concentration of all three antibodies waned with time post-vaccination, with IgM Spike and IgG Nucleocapsid waning faster than IgG Spike (RBD).


Subject(s)
Antibodies, Viral/blood , COVID-19 Vaccines/administration & dosage , COVID-19 , Health Personnel/statistics & numerical data , COVID-19/epidemiology , COVID-19/immunology , COVID-19/prevention & control , Cross-Sectional Studies , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Malaysia/epidemiology , Retrospective Studies , SARS-CoV-2 , Seroepidemiologic Studies , Spike Glycoprotein, Coronavirus
4.
Tropical Biomedicine ; : 552-560, 2021.
Article in English | WPRIM (Western Pacific) | ID: wpr-936378

ABSTRACT

@#Understanding of antibody kinetics against SARS-CoV-2 and its vaccines is rapidly evolving. This study aims to (1) determine post-vaccination seroprevalence; (2) compare antibody levels between vaccine types and various clinical/demographic determinants; and (3) determine post-vaccination antibody concentrations against time. This is a retrospective cross-sectional study involving 148 healthcare employees all over Malaysia. IgG Spike (RBD), IgM Spike and IgG Nucleocapsid concentration medians were compared using Mann-Whitney U or Kruskal-Wallis tests. Chi Square and Spearman correlation coefficient tests were performed to identify variables associated with antibody titers. A scatter plot of IgG Spike (RBD) against time from last vaccine dose was also plotted. At 1-month post-vaccination, all employees successfully seroconverted regardless of vaccine type, health status and COVID19 history. Comirnaty, convalescent, female or Malay vaccinees had significantly higher IgG Spike (RBD) titers compared to their respective counterparts. No correlation was found between age and IgG Spike (RBD) levels. Concentration of all three antibodies waned with time post-vaccination, with IgM Spike and IgG Nucleocapsid waning faster than IgG Spike (RBD).

5.
Dis Esophagus ; 32(6)2019 Jun 01.
Article in English | MEDLINE | ID: mdl-30462194

ABSTRACT

Long-term pharyngeal dysphagia is a common complication following head and neck cancer (HNC) therapies. High-level evidence for pharyngoesophageal junction (POJ) dilatation as a treatment in this population is lacking. We aimed to evaluate the safety and efficacy of POJ dilatation in dysphagic HNC survivors. This single-center, single-blind, placebo-controlled trial (St George Hospital, Sydney, Australia) randomly assigned (1:1) HNC survivors with long-term dysphagia (≥12 months postcompleted HNC therapies) to receive either graded endoscopic dilatations or sham dilatation (placebo). Patients were blinded to intervention types. Two strata were used for permuted randomization: (1) HNC therapies (total laryngectomy vs. chemoradiation alone); (2) Prior POJ dilatation (nil vs. previous dilatation). The primary endpoint was a short-term clinical response in swallowing function (3 months), defined as (1) a decrease in Sydney Swallow Questionnaire score by ≥200 or a score ≤ ULN; and (2) satisfactory global clinical assessment. The secondary endpoints were dysphagia relapse and serious adverse events. This trial is registered with the Australian New Zealand Clinical Trials Registry (ACTRN12617000707369). Between 13 January 2013 and 16 January 2017, 41 patients were randomly assigned to endoscopic dilatation (n = 21) or placebo (n = 20). The short-term response rate in the endoscopic dilatation group was 76% (n = 16), compared with 5% (n = 1) in the placebo group (P < 0.001). There were no serious adverse events. The finding of a mucosal tear postdilatation was associated strongly with clinical response (OR 13.4, 95% CI [2.4, 74.9], P = 0.003). Kaplan-Meier estimate of dysphagia relapse is 50% by 9.6 months (95% CI [6.0, 19.2]) from completion of dilatation. Endoscopic dilatation of the POJ is a safe and efficacious therapy for the treatment of long-term dysphagia in HNC survivors. Close follow-up and repeat dilatation are necessary given the high dysphagia relapse rate.


Subject(s)
Deglutition Disorders/therapy , Deglutition , Dilatation/methods , Head and Neck Neoplasms/therapy , Aged , Chemoradiotherapy/adverse effects , Chronic Disease , Deglutition Disorders/etiology , Deglutition Disorders/physiopathology , Dilatation/adverse effects , Endoscopy, Gastrointestinal/adverse effects , Female , Humans , Lacerations/etiology , Laryngectomy/adverse effects , Male , Middle Aged , Mucous Membrane/injuries , Prospective Studies , Recurrence , Single-Blind Method , Surveys and Questionnaires , Time Factors
6.
Am J Gastroenterol ; 113(2): 205-212, 2018 02.
Article in English | MEDLINE | ID: mdl-29206815

ABSTRACT

OBJECTIVES: Often 2-3 graduated pneumatic dilatations (PD) are required to treat achalasia as there is no current intra-procedural predictor of clinical response. Distensibility measurements using functional lumen imaging probe (FLIP) may provide an intra-procedural predictor of outcome. Our aim was to determine the optimal criterion for esophagogastric junction (EGJ) distensibility measurements during PD that predicts immediate clinical response. METHODS: EGJ distensibility was prospectively measured using FLIP immediately pre- and post-PD. The EGJ distensibility index (EGJ-DI) was defined as a ratio of the narrowest cross-sectional area and the corresponding intra-bag pressure at 40 ml distension. Immediate and short-term clinical responses were defined as Eckardt score ≤3 assessed 2 weeks Post-PD and at 3-month follow-up, respectively. RESULTS: In 54 patients, we performed thirty-seven 30 mm; twenty 35 mm and six 40 mm PDs. The short-term response rate to the graded PD was 93% (27/29) in newly diagnosed achalasia; 87% (13/15) and 70% (7/10) in those who had relapsed after previous PD and Heller's Myotomy, respectively. Among those demonstrating an immediate response, EGJ-DI increased by an average of 4.5 mm2/mmHg (95% CI (3.5, 5.5) (P<0.001). Within-subject Δ EGJ-DI was highly predictive of immediate clinical response with AUROC of 0.89 (95% CI [0.80, 0.98], P<0.001). An increment in EGJ-DI of 1.8 mm2/mmHg after a single PD predicts an immediate response with an accuracy of 87%. CONCLUSIONS: FLIP-measured Δ EGJ-DI is a novel intra-procedural tool that accurately predicts immediate clinical response to PD in achalasia. This technique may potentially dictate an immediate mechanism to "step-up" dilator size within a single endoscopy session.


Subject(s)
Dilatation/methods , Esophageal Achalasia/surgery , Esophagogastric Junction/surgery , Adult , Aged , Electric Impedance , Esophagogastric Junction/physiopathology , Female , Humans , Intraoperative Period , Male , Middle Aged , Pressure , Prognosis , Treatment Outcome
7.
Mult Scler ; 20(3): 286-94, 2014 Mar.
Article in English | MEDLINE | ID: mdl-23886832

ABSTRACT

BACKGROUND: Risk factors for multiple sclerosis (MS) include human leukocyte antigen (HLA)-DR and Epstein-Barr virus (EBV)-specific antibody responses, including an epitope within EBV nuclear antigen 1 (EBNA-1) that is of recent interest. OBJECTIVE: The objective of this paper is to assess case-control associations between MS risk and anti-EBV antibody levels as well as HLA-DR profiles, gender and age in a population-based cohort. METHODS: Serological responses to EBV were measured in 426 MS patients and 186 healthy controls. HLA-DR typing was performed using sequence-based methods. RESULTS: MS patients had significantly higher levels of antibodies against epitope-specific and polyspecific EBNA-1 and viral capsid antigen (VCA), compared with controls (all p < 10(-15)). In regression analyses, anti-EBNA-1 and anti-VCA antibody levels, protective HLA-DR*04/07/09 alleles and gender (all p < 0.003) contributed independently to a model that classified cases and controls with an odds ratio > 20 (sensitivity 92%, specificity 64%). Notably, the strong influence of high-risk HLA-DR alleles was abrogated after inclusion of EBV serology results. CONCLUSIONS: The ability to discriminate MS cases and controls can be substantially enhanced by including anti-EBV serology as well as HLA-DR risk profiles. These findings support the relevance of EBV-specific immunity in MS pathogenesis, and implicate both HLA-dependent and HLA-independent immune responses against EBNA-1 as prominent disease risk factors.


Subject(s)
Antibodies, Viral/immunology , Epstein-Barr Virus Nuclear Antigens/immunology , HLA-DR Antigens/genetics , Herpesvirus 4, Human/immunology , Multiple Sclerosis/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Alleles , Case-Control Studies , Female , Humans , Male , Middle Aged , Multiple Sclerosis/genetics , Multiple Sclerosis/immunology , Risk Factors , Sex Factors , Young Adult
8.
Transfus Med ; 22(5): 338-43, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22738179

ABSTRACT

OBJECTIVE: To describe patterns of clinical bleeding in neonates with severe thrombocytopenia (ST and platelet count <60 × 10(9) L(-1)), and to investigate the factors related to bleeding. STUDY DESIGN: Seven tertiary-level neonatal units enrolled neonates (n = 169) with ST. Data were collected prospectively on all clinically apparent haemorrhages. Relationships between bleeding, platelet count and baseline characteristics were explored through regression analysis. RESULTS: Bleeding was recorded in most neonates with ST (138/169; 82%), including 123 neonates with minor bleeding and 15 neonates with major bleeding. The most common sites of minor bleeding were from the renal tract (haematuria 40%), endotracheal tube (21%), nasogastric tube (10%) and skin (15%). Gestational age <34 weeks, development of ST within 10 days of birth and necrotizing enterocolitis were the strongest predictors for an increased number of bleeding events. For neonates with ST, a lower platelet count was not a strong predictor of increased bleeding. CONCLUSIONS: The majority of neonates with ST bleed, although most episodes are minor. These findings establish the importance of clinical factors for bleeding risk, rather than minimum platelet count. Further studies should assess the clinical significance of different types of minor bleed for neonatal outcomes, the predictive value of minor bleeding for major bleeding and the role of platelet transfusions in preventing bleeding.


Subject(s)
Hematuria/prevention & control , Platelet Transfusion , Thrombocytopenia/therapy , Female , Gestational Age , Hematuria/congenital , Humans , Infant , Infant, Newborn , Infant, Newborn, Diseases/therapy , Male , Prospective Studies , Thrombocytopenia/congenital
9.
Trop Biomed ; 28(1): 16-20, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21602764

ABSTRACT

Insects, in particular house flies and cockroaches, have been shown to be associated with the spread of pathogens in livestock farms and in human disease outbreaks: among these pathogens are salmonellae and campylobacters. A total of 60 flies were caught in three locations: an animal teaching facility and a cafeteria in a university campus, and a poultry farm. Five percent (5%) and 13.3% of flies sampled were found to carry Campylobacter and Salmonella, respectively.


Subject(s)
Campylobacter/isolation & purification , Houseflies/microbiology , Salmonella/isolation & purification , Animals , Humans , Malaysia , Prevalence , Rural Population , Urban Population
11.
J Econ Entomol ; 93(3): 905-10, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10902348

ABSTRACT

Susceptibility to deltamethrin of 10 strains of the German cockroach, Blattella germanica (L.), trapped in hotel kitchens in Singapore was determined. Two resistance detection bioassay methods (topical application and World Health Organization glass jar method) were compared. Resistance ratios based on 50% knockdown, obtained by comparison with the S strain, ranged from 17.7 to 4,235 for topical application and from 2.2 to 22 for the glass jar method. A field strain, with consistently low resistance ratios (topical method = 17.7, glass jar method = 2.2), was identified as a potential field strain to be used as a baseline for comparison with other field strains. Resistance ratios for the other field strains obtained by comparison with the R5 strain ranged from 24.5 to 239 for topical application and from 1.2 to 9.8 for the glass jar method. The results of our study demonstrate that deltamethrin-resistant German cockroaches are numerous in Singapore. Comparison between the two bioassay methods showed that there was significant correlation between KD50 and KT50 values. The glass jar method is similar to field situations but topical application is sensitive enough to define the magnitude of resistance. Differences between the two detection bioassays and the factors governing the choice of bioassay in monitoring resistance in German cockroaches are discussed.


Subject(s)
Biological Assay/methods , Blattellidae , Insecticides , Pyrethrins , Administration, Topical , Animals , Glass , Insect Control/methods , Insecticide Resistance , Male , Nitriles , World Health Organization
12.
Biophys J ; 71(4): 1672-9, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8889145

ABSTRACT

We report the first evidence of the structure of beta-amyloid protein as it exists in situ within a slice of human Alzheimer's diseased brain tissue. Using a Fourier transform infrared microspectroscopic technique, areas of interest can be selected for spectral measurements with regions of potential contamination masked. In so doing, it is possible to obtain infrared spectra only of beta-amyloid and not the surrounding grey matter within which it lies. However, to obtain spectra of high-quality signal-to-noise ratio using a conventional infrared source, we were limited to aperture sizes between 24 microns x 24 microns to 50 microns x 50 microns. Markedly improved high-quality spectra were acquired with infrared radiation provided by a synchrotron light source (National Synchrotron Light Source, Brookhaven National Laboratories), using aperture sizes as small as 12 microns x 12 microns. This allowed spectroscopic mapping of brain tissue regions containing amyloid. We observe that in situ protein of grey matter exist predominantly in an alpha-helical and/or unordered conformation, whereas within amyloid deposits a beta-sheet structure predominates. The hydrogen bonding strength of the beta-structure found in situ is different from that reported in the literature for isolated/chemically synthesized beta-amyloid peptides.


Subject(s)
Alzheimer Disease/pathology , Amyloid beta-Peptides/ultrastructure , Brain/pathology , Amyloid beta-Peptides/analysis , Autopsy , Humans , Protein Structure, Secondary , Reference Values , Spectroscopy, Fourier Transform Infrared/methods , Synchrotrons
13.
Artif Intell Med ; 7(1): 67-79, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7795717

ABSTRACT

Artificial neural network classification methods were applied to infrared spectra of histopathologically confirmed Alzheimer's diseased and control brain tissue. Principal component analysis was used as a preprocessing technique for some of these artificial neural networks while others were trained using the original spectra. The leave-one-out method was used for cross-validation and linear discriminant analysis was used as a performance benchmark. In the cases where principal components were used, the artificial neural networks consistently outperformed their linear discriminant counterparts; 100% versus 98% correct classifications, respectively, for the two class problem, and 90% versus 81% for a more complex five class problem. Using the original spectra, only one of the three selected artificial neural network architectures (a variation of the back-propagation algorithm using fuzzy encoding) produced results comparable to the best corresponding principal component cases: 98% and 85% correct classifications for the two and five class problems, respectively.


Subject(s)
Alzheimer Disease/classification , Alzheimer Disease/pathology , Brain/pathology , Diagnosis, Computer-Assisted , Neural Networks, Computer , Brain/cytology , Fuzzy Logic , Humans , Reference Values , Spectrophotometry, Infrared
14.
Biochim Biophys Acta ; 1270(1): 1-6, 1995 Jan 25.
Article in English | MEDLINE | ID: mdl-7827129

ABSTRACT

Infrared spectra of human central nervous system tissue and human breast carcinoma are presented. The spectra are discussed in terms of the composition of the tissues. It is shown that differences between spectra of white and grey matter can be rationalised on the basis of differences in lipid content. Spectra of the choroid plexus and arachnoid villus of the meninges show a series of absorptions not observed in other CNS tissue. These absorptions are discussed in terms of the connective tissue content of the samples. We demonstrate that the presence of collagen results in the appearance of a series of characteristic absorptions which may be mis-assigned as DNA phosphate absorptions. The implications of the presence of collagen in tissues for the diagnosis of disease states by IR spectroscopic methods, with particular reference to cancer, is discussed.


Subject(s)
Central Nervous System/chemistry , Collagen/chemistry , Connective Tissue/chemistry , Brain Chemistry , Breast Neoplasms/chemistry , Humans , Spectroscopy, Fourier Transform Infrared
15.
Biochem J ; 301 ( Pt 3): 667-70, 1994 Aug 01.
Article in English | MEDLINE | ID: mdl-7519846

ABSTRACT

Fourier-transform i.r. (f.t.i.r.) spectroscopy has been applied to the study of the conformational properties of substance P in aqueous solution. Spectra were obtained in the presence of lipid membranes and Ca2+ to assess the role of these factors in induction of the active conformation of the peptide. In aqueous solution substance P was found to be predominantly unstructured at physiological p2H, where the lack of long-range order is probably related to charge repulsion along the peptide chain. However, substance P aggregated in aqueous solution at p2H > 10.0. Little or no induction of secondary structure was seen on addition of the peptide to negatively charged bilayers, suggesting that interaction with a membrane surface does not play an important role in the stabilization of the active conformation of the peptide. In fact, substance P was found to aggregate in the presence of charged lipids, which would tend to hinder rather than enhance interaction with the receptor. We propose a model for the aggregation of substance P at the bilayer surface, based on our studies of the effect of p2H and lipid/peptide ratio on spectra. Addition of Ca2+ had no effect upon the secondary structure of the peptide or on its interactions with membranes.


Subject(s)
Spectroscopy, Fourier Transform Infrared , Substance P/chemistry , Amino Acid Sequence , Calcium/pharmacology , Electrochemistry , Hydrogen Bonding , Hydrogen-Ion Concentration , Membrane Lipids/pharmacology , Molecular Sequence Data , Phospholipids/pharmacology , Protein Conformation/drug effects , Protein Structure, Secondary
16.
Biochim Biophys Acta ; 1182(3): 333-7, 1993 Oct 20.
Article in English | MEDLINE | ID: mdl-8399370

ABSTRACT

Fourier transform infrared spectroscopy has been used for the characterisation of white matter, grey matter and multiple sclerosis plaques from human central nervous system tissue. We demonstrate significant differences in the infrared spectra of the three types of tissue, which show that an infrared spectroscopic discrimination of multiple sclerosis plaques from healthy brain tissue is possible in principle. The spectral changes reveal pronounced lipid loss in plaques, consistent with the demyelinating nature of the disease. The chronic plaques studied here can also be distinguished from other non-myelinated areas of the brain, based on differences in water content.


Subject(s)
Brain Chemistry , Multiple Sclerosis/pathology , Spinal Cord/chemistry , Amides , Humans , Lipids , Multiple Sclerosis/diagnosis , Proteins , Spectrophotometry, Infrared/methods , Water
17.
Can J Physiol Pharmacol ; 70(10): 1403-7, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1490258

ABSTRACT

We tested the hypothesis that the atrial natriuretic peptide (ANP) mediated decrease in baroreceptor sensitivity that is seen in normal rats is more pronounced in a state of depressed cardiac performance. Holtzman rats (n = 15) were injected with Adriamycin (1 mg/kg i.p. 3 times/week for 8-10 weeks). Control rats (n = 17) were injected with 0.9% saline. Experiments were done in conscious animals that had been catheterized for i.v. infusions and for measurement of arterial blood pressure (ABP) and heart rate (HR). ANP (250 ng.kg-1.min-1) or saline vehicle was infused i.v. Graded periodic bolus injections of phenylephrine or sodium nitroprusside were given to assess baroreceptor sensitivity (beats.min-1.mmHg-1) up to 60 mmHg (1 mmHg = 133.3 Pa) above and below resting ABP. The following day the experiment was repeated with the ANP-vehicle regimen reversed. Finally, the rats were anesthetized and the rate of left ventricular pressure increase (dP/dt) was measured. Data evaluation included calculation of least squares linear regression slopes of peak delta HR vs. peak delta ABP, applying corrections for experimental errors in both the dependent and independent variables. Adriamycin rats (A) did not differ significantly from control rats (C) with respect to either initial ABP (A = 105 +/- 5; C = 100 +/- 3; mean mmHg +/- SEM) or initial HR (335 +/- 9 vs. 312 +/- 13 beats.min-1). However, their indices of cardiac performance were significantly depressed.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Atrial Natriuretic Factor/physiology , Cardiac Output, Low/physiopathology , Pressoreceptors/physiology , Animals , Blood Pressure/physiology , Cardiac Output, Low/chemically induced , Doxorubicin , Heart Rate/physiology , Male , Rats , Reflex/physiology , Regression Analysis
18.
Naunyn Schmiedebergs Arch Pharmacol ; 345(3): 288-95, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1352380

ABSTRACT

The ability of several selective muscarine receptor antagonists to inhibit the effect of carbachol on prejunctional muscarine receptors on sympathetic nerve endings in the rabbit isolated ear artery was investigated to characterise the receptor subtype involved. Carbachol did not reduce responses to exogenous noradrenaline and the inhibitory effect of carbachol on responses to nerve stimulation was unaffected by hexamethonium (10 microM) indicating that the effect of the muscarine agonist was exerted prejunctionally and was not modulated by nicotine receptor stimulation. The dissociation constants or apparent dissociation constants obtained using (+/-)-benzhexol (pKB; 6.63), (R)-benzhexol methiodide (8.11), dicyclomine (5.86), (+/-)-telenzepine (7.34), AF-DX 116 (6.95), himbacine (7.60), (+/-)-hexahydrosiladiphenidol (5.39) and a bisquaternary ammonium compound, heptane-1,7-bis(dimethyl-3'-phthalimidopropyl ammonium bromide) (5.84), indicate that the muscarine receptor subtype involved is not of the M1, M2 or M3 subtype.


Subject(s)
Arteries/ultrastructure , Ear, External/blood supply , Receptors, Muscarinic/classification , Animals , Arteries/drug effects , Arteries/innervation , Carbachol/antagonists & inhibitors , Carbachol/pharmacology , Dicyclomine/pharmacology , Guinea Pigs , Heart Atria/drug effects , Hexamethonium , Hexamethonium Compounds/pharmacology , Ileum/drug effects , Ileum/ultrastructure , In Vitro Techniques , Kinetics , Muscarinic Antagonists , Muscle, Smooth/drug effects , Muscle, Smooth/ultrastructure , Neuromuscular Junction/drug effects , Neuromuscular Junction/ultrastructure , Rabbits , Trihexyphenidyl/pharmacology
19.
J Auton Pharmacol ; 11(2): 109-19, 1991 Apr.
Article in English | MEDLINE | ID: mdl-1710620

ABSTRACT

1. The effect of temperature reduction on the interaction of carbachol (CCh) and McN-A-343 (McN) with muscarinic receptors in the guinea-pig taenia caeci was investigated. 2. McN, a partial agonist, acted on the smooth muscle to produce contraction. The response was unaffected by tetrodotoxin and the pKB for inhibition by pirenzepine was 6.8, indicating that ganglionic M1 receptors were not involved in the response. 3. Reduction in temperature from 37 degrees C to 18 degrees C for 3 h led to a marked reduction in the contractile response to McN (2-200 microM) but no reduction in the response to CCh (0.1-3 microM). 4. The reduction in temperature was not accompanied by any change in the affinity of McN or CCh for muscarine receptors in binding experiments with [3H]-QNB. 5. The KA value for CCh determined after irreversible receptor inactivation with propylbenzilylcholine mustard followed by ca 60-min wash-out was 7.6 microM, a value similar to that obtained in binding experiments. 6. The EC50 for McN in producing contraction at 37 degrees C (2.1 microM) was similar to the KA value for the partial agonist obtained in experiments with the irreversible antagonist phenoxybenzamine (2.5 microM). It was also similar to the KB value determined at 18 degrees C (3.4 microM) when McN could be used as an antagonist of contractions to CCh. 7. At 18 degrees C, phosphatidylinositol (PI) hydrolysis by CCh was reduced to 23% of that at 37 degrees C. 8. It is concluded that reduction of muscarinic receptor activation of the PI pathway by cholinomimetics with lowering of the temperature could account for the findings with McN on contractility.


Subject(s)
Colon/drug effects , Parasympathomimetics/pharmacology , Temperature , (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride/pharmacology , Animals , Atropine/pharmacology , Carbachol/pharmacology , Drug Interactions , Guinea Pigs , In Vitro Techniques , Inositol Phosphates/metabolism , Kinetics , Muscle Contraction/drug effects , Phenoxybenzamine/pharmacology , Pirenzepine/pharmacology , Propylbenzilylcholine Mustard/pharmacology , Quinuclidinyl Benzilate/metabolism
20.
Clin Exp Pharmacol Physiol ; 17(9): 601-11, 1990 Sep.
Article in English | MEDLINE | ID: mdl-1703935

ABSTRACT

1. The effect of several selective muscarine receptor antagonists were evaluated on the responses of carbachol (CCh) and McN-A-343 (McN) during sympathetic nerve stimulation in the rabbit vas deferens. 2. The muscarine M1 receptor antagonist pirenzepine exhibited similar apparent pKB values for antagonism of the prejunctional inhibitory response of either CCh (pKB, 8.2) or McN (pKB, 8.5) on sympathetic nerve stimulation. 3. The muscarine M2 receptor antagonists, pancuronium and the bisalkyl ammonium compound 'C7/3-phth' were selective inhibitors of the postjunctional facilitatory response produced by CCh on sympathetic nerve stimulation. They were also 17- and three-fold, respectively, less potent against the inhibitory responses of McN on sympathetic nerve stimulation. The apparent pKB value of pancuronium on the inhibitory response produced by CCh did not differ significantly (P greater than 0.05) from that using McN. A similar finding was made for C7/3-phth. 4. Selective blockade of the inhibitory response to CCh with pirenzepine (0.03 or 0.5 mumol/L) did not significantly (P greater than 0.05) modify the apparent pKB value for pancuronium on the facilitatory response of CCh. 5. Selective blockade of the facilitatory response to CCh with a low concentration of pancuronium (0.5 mumol/L) did not significantly (P greater than 0.05) modify the apparent pKB value for pancuronium (30 mumol/L) on the inhibitory response of CCh. 6. It is suggested that CCh and McN activate the same prejunctional M1 muscarine receptor and that pancuronium is the most selective of the muscarine M2 receptor antagonists presently tested in this preparation for distinguishing between muscarine M1 and M2 receptors.


Subject(s)
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride/antagonists & inhibitors , Carbachol/antagonists & inhibitors , Muscle, Smooth/drug effects , Animals , Bis-Trimethylammonium Compounds/pharmacology , Cocaine/pharmacology , Electric Stimulation , In Vitro Techniques , Isoindoles , Male , Muscarinic Antagonists , Muscle Contraction/drug effects , Muscle, Smooth/innervation , Pancuronium/pharmacology , Pirenzepine/analogs & derivatives , Pirenzepine/pharmacology , Rabbits , Vas Deferens/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...